Complication, Survival, and Reoperation Rates Following Girdlestone Resection Arthroplasty

The Journal of Arthroplasty
Tennison L MalcolmCarlos A Higuera

Abstract

Failed hip arthroplasty patients unsuitable for reimplantation may be offered Girdlestone resection arthroplasty (GRA). The purpose of this study was to detail complication and failure rates following GRA. Our results show that 66% (25/38), 34% (13/38), and 76% (29/38) of GRA patients experienced minor, major, and overall complications, respectively. Within 90 days of surgery, three patients required additional surgery and four died. Reoperation or death occurred an average of 26.3 (SD=3.5) and 55.6 (SD=76) months after surgery, respectively. Male gender and increasing comorbidity significantly predicted higher reoperation and mortality rates, P=0.01 and P=0.04, respectively. Complication and mortality rates following GRA are among the highest reported succeeding elective hip surgery for non-traumatic etiology.

References

Oct 1, 1982·Clinical Orthopaedics and Related Research·E S Bittar, W Petty
Sep 5, 1998·International Orthopaedics·J CastellanosA Navarro
Jan 26, 2005·Journal of Orthopaedic Trauma·Yoshimi EndoKenneth J Koval
Feb 11, 2005·International Orthopaedics·H SharmaD I Rowley
Mar 3, 2005·The Journal of Bone and Joint Surgery. American Volume·Kevin J BozicJonathan Showstack
Jan 4, 2007·The Journal of Bone and Joint Surgery. American Volume·Javad ParviziRichard H Rothman
Apr 4, 2007·The Journal of Bone and Joint Surgery. American Volume·Steven KurtzMichael Halpern
Sep 11, 2007·The Journal of Arthroplasty·Daniel T AlfonsoPaul E Di Cesare
Sep 6, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Joan D PenrodAlbert L Siu
Jul 3, 2009·The Journal of Bone and Joint Surgery. American Volume·Kevin J BozicDaniel J Berry
Jan 17, 2012·The Journal of Arthroplasty·Karl KoenigStuart B Goodman

❮ Previous
Next ❯

Citations

Apr 15, 2016·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Riccardo D'AmbrosiRenato Mario Facchini
Feb 15, 2018·Postgraduate Medical Journal·Nainesha Kulkarni, Abhishek Chitnis
Dec 2, 2018·The Bone & Joint Journal·J R GillM J Parker
May 5, 2018·British Journal of Hospital Medicine·Hosam E MatarNicholas Emms
Mar 31, 2019·Archives of Orthopaedic and Trauma Surgery·Konstantinos Anagnostakos, Christof Meyer
Jul 14, 2018·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Jung-Taek KimPil Whan Yoon
Feb 25, 2021·Archives of Orthopaedic and Trauma Surgery·Alireza K NazemiAlexandra I Stavrakis
Aug 28, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Gregory J KirchnerLucas E Nikkel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Absence Epilepsy

Absence epilepsy is a common seizure disorder in children which can produce chronic psychosocial sequelae. Discover the latest research on absence epilepsies here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Revue de chirurgie orthopédique et réparatrice de l'appareil moteur
R M D'AUBIGNE, M POSTEL
La Chirurgia degli organi di movimento
V MonteleoneV Galluzzi
© 2022 Meta ULC. All rights reserved